Federal contract award
75F40124C00134
BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541720 — Research and Development in the Social Sciences and Humanities |
| PSC | AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | TIME AND MATERIALS |
| Obligations | $1.3M |
| Current contract value | $1.3M |
| Potential contract value / ceiling | $1.3M |
| Start date | Sep 24, 2024 |
| Current end date | Nov 22, 2027 |
| Potential end date | Nov 22, 2027 |
| Latest award activity | Jul 24, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 24, 2026 | P00007 | $0 | EO 14398 - THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE DELIVERABLES TIMETABLE FOR PHASE II ACTIVITIES TO REFLECT THE PROJECT TIMELINE. |
| Apr 15, 2026 | P00006 | $801.6K | BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS. |
| Jan 6, 2026 | P00005 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO 04/13/2026. |
| Jul 16, 2025 | P00004 | $0 | COR CHANGE. |
| Jan 16, 2025 | P00003 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO FEBRUARY 02, 2026. |
| Jan 14, 2025 | P00002 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO FEBRUARY 02, 2026. |
| Oct 31, 2024 | P00001 | $0 | MOD P00001 - TO CHANGE CONTRACT TYPE FOR BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS. |
| Sep 24, 2024 | 0 | $497.6K | BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS. |
Estimated positioning window
Nov 22, 2026 – May 22, 2027
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2027-11-22 (393 days from calculation)
- +25 points
- 4 historical awards in this buyer and category group
- +15 points
- 8 recorded award transactions
- +10 points
- Latest award action: 2026-07-24
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.